Joe Seldner ’84, founder of the Senior Poverty Prevention Project, calls for problem solvers to take on an issue getting little attention.
A growing pool of ESG data enumerates companies’ exposure to climate risk. Yale SOM’s Todd Cort explains how the data helps investors target capital toward the companies that are responding.
Dr. Cecelia Calhoun ’21, a Yale physician with a focus on sickle cell disease, and Yale SOM’s Dr. Howard Forman discuss the gargantuan but critical challenge of addressing the impact of systemic racism on the health of Black Americans.
The healthcare industry produces 8.5% of all U.S. greenhouse gas emissions as well as other forms of air pollution. Yale's Dr. Jodi Sherman says the first step to making healthcare sustainable is to understand the scope of the problem.
Investors are increasingly eager to contribute to solutions for climate change and other environmental problems. Charlotte Kaiser ’07 of The Nature Conservancy’s NatureVest explains how the company builds financial products that attract mainstream capital while delivering conservation impacts.
Professor Teresa Chahine talks with Roderick Bremby, who led a dramatic turnaround of Connecticut's Supplemental Nutrition Assistance Program. Today, he is an executive at Salesforce, which has provided contact tracing and vaccine management during the COVID-19 pandemic.
Vincent Stanley, Patagonia’s company philosopher, chronicles the company’s efforts to bring environmental and social values to the heart of what the company does.
Josh Geballe ’02, Connecticut’s chief operating officer, explains the state’s controversial decision to switch to age-based eligibility for COVID vaccines—and says it likely saved lives.
Elliot Mainzer ’98, CEO of CAISO, explains how California is working to avoid another summer of blackouts even as the state transitions to a carbon-neutral grid.
Texas-based energy economist Ed Hirs ’81 says the February 2021 power crisis exposed longstanding, fatal flaws in the state’s energy market design and oversight.